Period | Model 1 | Model 2 | Model 3 | Model 4 | |
PR (95% CI) | PR (95% CI) | PR (95% CI) | PR (95% CI) | ||
Men | 2006 vs 2004 (ref) | 0.74 (0.61 to 0.89)** | 0.75 (0.62 to 0.92)** | 0.76 (0.63 to 0.92)** | 0.77 (0.64 to 0.93)** |
2008 vs 2006 (ref) | 1.33 (1.09 to 1.62)** | 1.28 (1.05 to 1.55)* | 1.38 (1.14 to 1.68)** | 1.34 (1.10 to 1.63)** | |
2010 vs 2008 (ref) | 1.36 (1.16 to 1.59)*** | 1.36 (1.17 to 1.59)*** | 1.21 (1.03 to 1.41)* | 1.22 (1.04 to 1.43)* | |
2012 vs 2010 (ref) | 0.85 (0.73 to 0.98)* | 0.85 (0.74 to 0.99)* | 0.90 (0.78 to 1.04) | 0.90 (0.78 to 1.04) | |
2014 vs 2012 (ref) | 0.87 (0.73 to 1.03) | 0.87 (0.74 to 1.04) | 0.90 (0.76 to 1.06) | 0.90 (0.76 to 1.07) | |
2016 vs 2014 (ref) | 0.94 (0.78 to 1.13) | 0.93 (0.77 to 1.12) | 0.92 (0.77 to 1.11) | 0.91 (0.76 to 1.10) | |
Women | 2006 vs 2004 (ref) | 0.86 (0.75 to 0.98)* | 0.86 (0.76 to 0.99)* | 0.85 (0.74 to 0.97)* | 0.85 (0.74 to 0.97)* |
2008 vs 2006 (ref) | 1.15 (1.01 to 1.32)* | 1.16 (1.01 to 1.32)* | 1.18 (1.04 to 1.36)* | 1.19 (1.04 to 1.36)* | |
2010 vs 2008 (ref) | 1.25 (1.11 to 1.40)*** | 1.24 (1.11 to 1.40)*** | 1.22 (1.09 to 1.38)** | 1.22 (1.09 to 1.37)** | |
2012 vs 2010 (ref) | 0.85 (0.76 to 0.95)** | 0.85 (0.76 to 0.95)** | 0.86 (0.76 to 0.96)** | 0.85 (0.76 to 0.96)** | |
2014 vs 2012 (ref) | 0.89 (0.78 to 1.02) | 0.89 (0.78 to 1.01) | 0.91 (0.80 to 1.03) | 0.91 (0.80 to 1.03) | |
2016 vs 2014 (ref) | 1.01 (0.88 to 1.15) | 1.01 (0.88 to 1.16) | 0.98 (0.86 to 1.12) | 0.98 (0.86 to 1.12) |
Model 1: unadjusted; model 2: adjusted for age, ethnicity and marital status; model 3: adjusted for education, income, economic activity; model 4: adjusted for age, ethnicity, marital status, education, income, economic activity.
Statistically significant difference: *p<0.05, **p<0.01, ***p<0.001.
PR, prevalence ratios.